BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 3 filers reported holding BIODELIVERY SCIENCES INTL IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $3,000 | -25.0% | 1,000 | 0.0% | 0.00% | – |
Q3 2021 | $4,000 | – | 1,000 | +2841.2% | 0.00% | – |
Q2 2021 | $0 | – | 34 | -71.2% | 0.00% | – |
Q3 2018 | $0 | -100.0% | 118 | -100.0% | 0.00% | – |
Q1 2016 | $1,652,000 | -87.2% | 511,479 | -81.1% | 0.00% | -100.0% |
Q4 2015 | $12,949,000 | +280.3% | 2,703,352 | +341.4% | 0.00% | – |
Q3 2015 | $3,405,000 | -34.6% | 612,456 | -6.4% | 0.00% | -100.0% |
Q2 2015 | $5,208,000 | -24.3% | 654,299 | -0.1% | 0.00% | 0.0% |
Q1 2015 | $6,877,000 | -72.8% | 654,999 | -68.9% | 0.00% | -66.7% |
Q4 2014 | $25,308,000 | -37.8% | 2,105,499 | -11.5% | 0.00% | -50.0% |
Q3 2014 | $40,676,000 | +25.6% | 2,380,099 | -11.3% | 0.01% | +50.0% |
Q2 2014 | $32,384,000 | +26.0% | 2,682,983 | -11.9% | 0.00% | 0.0% |
Q1 2014 | $25,705,000 | +49.1% | 3,045,583 | +4.0% | 0.00% | +100.0% |
Q4 2013 | $17,244,000 | -44.2% | 2,927,631 | -48.5% | 0.00% | -60.0% |
Q3 2013 | $30,893,000 | +46.7% | 5,689,300 | +9.7% | 0.01% | +66.7% |
Q2 2013 | $21,056,000 | – | 5,186,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 1,575,000 | $6,615,000 | 4.38% |
1492 Capital Management LLC | 790,863 | $3,322,000 | 1.91% |
Rubric Capital Management LP | 3,516,124 | $14,768,000 | 1.08% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 9,530,000 | $40,026,000 | 0.79% |
Zebra Capital Management LLC | 144,241 | $606,000 | 0.77% |
KNOTT DAVID M | 370,230 | $1,555,000 | 0.70% |
Nantahala Capital Management | 5,123,671 | $21,519,000 | 0.67% |
SYSTEMATIC FINANCIAL MANAGEMENT LP | 3,593,893 | $15,094,000 | 0.66% |
EMC Capital Management | 98,933 | $416,000 | 0.32% |
ALGERT GLOBAL LLC | 175,170 | $736,000 | 0.21% |